ClearPoint Neuro, Inc.

NasdaqCM CLPT

ClearPoint Neuro, Inc. Shareholders' Equity for the quarter ending September 30, 2024: USD 29.00 M

ClearPoint Neuro, Inc. Shareholders' Equity is USD 29.00 M for the quarter ending September 30, 2024, a 20.37% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • ClearPoint Neuro, Inc. Shareholders' Equity for the quarter ending September 30, 2023 was USD 24.09 M, a -39.58% change year over year.
  • ClearPoint Neuro, Inc. Shareholders' Equity for the quarter ending September 30, 2022 was USD 39.88 M, a -9.61% change year over year.
  • ClearPoint Neuro, Inc. Shareholders' Equity for the quarter ending September 30, 2021 was USD 44.12 M, a 29,490.88% change year over year.
  • ClearPoint Neuro, Inc. Shareholders' Equity for the quarter ending September 30, 2020 was USD 149.10 K, a -97.52% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
NasdaqCM: CLPT

ClearPoint Neuro, Inc.

CEO Mr. Joseph Michael Burnett
IPO Date May 22, 2012
Location United States
Headquarters 120 S. Sierra Avenue
Employees 107
Sector Healthcare
Industries
Description

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Similar companies

INGN

Inogen, Inc.

USD 11.69

-2.18%

NPCE

NeuroPace, Inc.

USD 13.76

-3.03%

SGHT

Sight Sciences, Inc.

USD 2.80

-5.72%

SRDX

Surmodics, Inc.

USD 34.04

-4.06%

TELA

TELA Bio, Inc.

USD 2.64

-0.75%

INSP

Inspire Medical Systems, Inc.

USD 193.50

-0.63%

RCEL

AVITA Medical, Inc.

USD 9.10

-3.91%

LIVN

LivaNova PLC

USD 49.95

-1.36%

ELMD

Electromed, Inc.

USD 34.40

-2.11%

APYX

Apyx Medical Corporation

USD 1.44

-5.26%

NARI

Inari Medical, Inc.

USD 79.67

-0.03%

KIDS

OrthoPediatrics Corp.

USD 24.00

-0.58%

TMCI

Treace Medical Concepts, Inc.

USD 10.05

0.20%

LUNG

Pulmonx Corporation

USD 5.68

-0.18%

StockViz Staff

February 3, 2025

Any question? Send us an email